Balaji Amines Limited

Equities

BALAMINES

INE050E01027

Specialty Chemicals

Market Closed - Bombay S.E. 11:57:00 2024-04-24 pm EDT 5-day change 1st Jan Change
2,240 INR -0.27% Intraday chart for Balaji Amines Limited +1.59% -16.10%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
India Ratings Keeps Balaji Amines Rating at AA; Outlook Stable MT
Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Balaji Amines Begins Commercial Production of N-Butylamines at Maharashtra Unit MT
Transcript : Balaji Amines Limited, Q2 2024 Earnings Call, Nov 10, 2023
Balaji Amines Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Balaji Amines Arm Balaji Speciality Chemicals Withdraws Filing for IPO MT
Transcript : Balaji Amines Limited, Q1 2024 Earnings Call, Sep 08, 2023
Balaji Amines Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Balaji Amines Limited Approves Dividend for the Financial Year 2022-23 CI
Transcript : Balaji Amines Limited, Q4 2023 Earnings Call, May 22, 2023
Balaji Amines Limited Announces Resignation of Hemanth Reddy Gaddam as Chief Financial Officer CI
Balaji Amines CFO Resigns MT
Balaji Amines Limited Announces Board Changes CI
Balaji Amines Limited Recommends Final Dividend for the Year Ended March 31, 2023 CI
Balaji Amines Limited Appoints Ande Srinivas Reddy as CFO CI
Balaji Amines Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Balaji Amines Clocks Rise in Fiscal Q2 Consolidated Profit; Shares Slide 4% MT
Balaji Amines Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Balaji Amines Begins Commercial Production of Dimethyl Carbonate at New Unit MT
Balaji Amines Limited Intimation of Commencement of Commercial Production of DMC at MIDC, Chincholi, Solapur CI
Balaji Amines Commissions New Greenfield Unit in Maharashtra, India; Starts Construction of Two New Plants MT
Balaji Amines Limited Completes Phase 1 of Greenfield Project CI
Balaji Amines Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Balaji Amines Subsidiary Files Draft Papers for IPO MT
Chart Balaji Amines Limited
More charts
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Company’s segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,246 INR
Average target price
2,742 INR
Spread / Average Target
+22.08%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BALAMINES Stock
  4. News Balaji Amines Limited
  5. Balaji Amines Posts Rise in Fiscal Q4 Consolidated Net Profit, Revenue